A Study to Find Out The Effect of Amrutveni LiceQit shampoo in Managing Head Lice Infestation

A prospective, open-label, single-arut interventional clinical test to evaluate the effectiveness of Amrutveni Liceeit shampoo in the management of head lice infestation - nil

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/11/098109

Enrollment

Registered

2025-11-26

Start date

Unknown

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B85- Pediculosis and phthiriasis

Interventions

Intervention1: Amrutveni LiceQit Shampoo: Type of Product: Herbal topical formulation (cosmeceutical / therapeutic shampoo) Dosage Form: shampoo (for external application on scalp and hair) Route of A

Eligibility

Inclusion criteria

Inclusion criteria: Individuals aged between 10 and 55 years Presence of head Lice infestation

Exclusion criteria

Exclusion criteria: Known allergy or hypersensitivity to any of the ingredients in Amrutveni LiceQit Shampoo Active scalp conditions such as psoriasis, seborrheic dermatitis, eczema, or open scalp wounds Use of any pediculicidal treatment within the preceding 7 days Participation in any other interventional clinical study within the last 30 days Pregnant or lactating women

Design outcomes

Primary

Measure	Time frame
Outcome TimePoints Mean percentage reduction in live lice and nit count from baseline (Day 0) to Day 28, determined by standardized lice detection combing and count comparisonTimepoint: Day 0 (baseline), Day 1 7, Day 14, Day 21	—

Secondary

Measure	Time frame
Outcome TimePoints 1. Change in Pediculosis Severity Score (PSS) from Day 0 to Day 28. 2. Change in itching intensity (VAS, 0 10). 3. Change in scalp inflammation/redness (0 3 scale). 4. Improvement in hair texture, softness, and manageability. 5. Change in hair volume and tangle score. 6. Overall subject satisfaction (1 5 Likert scale). 7. Incidence of local irritation, erythema, allergic reaction, and overall safety (IGDES score).Timepoint: Day 0 (baseline), Day 1 7, Day 14, Day 21,	—

Measure

Time frame

Outcome TimePoints 1. Change in Pediculosis Severity Score (PSS) from Day 0 to Day 28. 2. Change in itching intensity (VAS, 0 10). 3. Change in scalp inflammation/redness (0 3 scale). 4. Improvement in hair texture, softness, and manageability. 5. Change in hair volume and tangle score. 6. Overall subject satisfaction (1 5 Likert scale). 7. Incidence of local irritation, erythema, allergic reaction, and overall safety (IGDES score).Timepoint: Day 0 (baseline), Day 1 7, Day 14, Day 21,

—

Countries

India

Contacts

Public ContactDr Kasthuri Nair A

Pankajakasthuri Ayurveda Medical college and PG centre

dr.kasthurinair@pkhil.com8113851665

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026